Literature DB >> 11243848

Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.

D Goto1, H Nakajima, Y Mori, K Kurasawa, N Kitamura, I Iwamoto.   

Abstract

Regulation of subcellular localization of Smad proteins is supposed to be critical for the effective initiation and maintenance of TGF-beta signaling. Recently, Smad anchor for receptor activation (SARA) has been identified as a Smad2 binding protein. SARA regulates the subcellular localization of Smad2 and is required for TGF-beta/Smad2-mediated signaling. In this study, we determined whether the interaction between SARA and Smad3 is essential for TGF-beta/Smad3-mediated signaling. We found that a mutant Smad3 (Smad3NS) that lacked the binding to SARA was phosphorylated by TGF-beta type I receptor at the similar level to that in wild-type Smad3 (Smad3WT). Smad3NS also formed complexes with Smad4 and translocalized into the nucleus. Moreover, Smad3NS and Smad3WT equally enhanced TGF-beta-induced transcription. Therefore, these findings indicate that, in contrast to SARA/Smad2 interaction, SARA/Smad3 interaction is not essential for TGF-beta/Smad3-mediated signaling. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243848     DOI: 10.1006/bbrc.2001.4489

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  TGFβ superfamily signaling regulators are differentially expressed in the developing and adult mouse testis.

Authors:  Catherine Itman; Chin Wong; Penny Af Whiley; Dhanushi Fernando; Kate L Loveland
Journal:  Spermatogenesis       Date:  2011-01

2.  The NH2-terminal propeptide of type I procollagen acts intracellularly to modulate cell function.

Authors:  Anush Oganesian; Sandra Au; Jeremy A Horst; Lars C Holzhausen; Athena J Macy; James M Pace; Paul Bornstein
Journal:  J Biol Chem       Date:  2006-10-03       Impact factor: 5.157

Review 3.  Signaling pathways and therapeutic interventions in gastric cancer.

Authors:  Zi-Ning Lei; Qiu-Xu Teng; Qin Tian; Wei Chen; Yuhao Xie; Kaiming Wu; Qianlin Zeng; Leli Zeng; Yihang Pan; Zhe-Sheng Chen; Yulong He
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

4.  Hypoxia Selectively Increases a SMAD3 Signaling Axis to Promote Cancer Cell Invasion.

Authors:  Karine Brochu-Gaudreau; Martine Charbonneau; Kelly Harper; Claire M Dubois
Journal:  Cancers (Basel)       Date:  2022-06-01       Impact factor: 6.575

Review 5.  New Player in Endosomal Trafficking: Differential Roles of Smad Anchor for Receptor Activation (SARA) Protein.

Authors:  Victoria Rozés-Salvador; Sebastian O Siri; Melina M Musri; Cecilia Conde
Journal:  Mol Cell Biol       Date:  2018-11-28       Impact factor: 4.272

6.  Role of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotype.

Authors:  Constance E Runyan; Tomoko Hayashida; Susan Hubchak; Jessica F Curley; H William Schnaper
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157

7.  Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells.

Authors:  Amber C Liu; Avrum I Gotlieb
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

Review 8.  TGF-beta signal transduction in chronic kidney disease.

Authors:  H William Schnaper; Sara Jandeska; Constance E Runyan; Susan C Hubchak; Rajit K Basu; Jessica F Curley; Ronald D Smith; Tomoko Hayashida
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

9.  Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin.

Authors:  Justin B Goh; Daniel F Wallace; Wanjin Hong; V Nathan Subramaniam
Journal:  Sci Rep       Date:  2015-09-11       Impact factor: 4.379

10.  The FYVE domain of Smad Anchor for Receptor Activation (SARA) is required to prevent skin carcinogenesis, but not in mouse development.

Authors:  Huang-Ming Chang; Yu-Ying Lin; Pei-Chun Tsai; Chung-Tiang Liang; Yu-Ting Yan
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.